Jonathan S. Nguyen‐Van‐Tam

21.9k total citations · 4 hit papers
168 papers, 7.5k citations indexed

About

Jonathan S. Nguyen‐Van‐Tam is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Jonathan S. Nguyen‐Van‐Tam has authored 168 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Epidemiology, 42 papers in Infectious Diseases and 32 papers in Modeling and Simulation. Recurrent topics in Jonathan S. Nguyen‐Van‐Tam's work include Influenza Virus Research Studies (98 papers), Respiratory viral infections research (53 papers) and COVID-19 epidemiological studies (32 papers). Jonathan S. Nguyen‐Van‐Tam is often cited by papers focused on Influenza Virus Research Studies (98 papers), Respiratory viral infections research (53 papers) and COVID-19 epidemiological studies (32 papers). Jonathan S. Nguyen‐Van‐Tam collaborates with scholars based in United Kingdom, United States and Switzerland. Jonathan S. Nguyen‐Van‐Tam's co-authors include Wei Shen Lim, Charles Beck, Jo Leonardi‐Bee, Chamira Rodrigo, Louise Lansbury, Ben Killingley, Karl G. Nicholson, Puja Myles, J. Kenneth Baillie and A. Ahmed and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Jonathan S. Nguyen‐Van‐Tam

162 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

2014 656 citations Wei Shen Lim, Jonathan S. Nguyen‐Van‐Tam et al. profile →
Middle East Respiratory Syndrome

2017 373 citations Jonathan S. Nguyen‐Van‐Tam et al. profile →
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

2021 196 citations Malcolm G. Semple, Andrew Hayward et al. profile →
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries

2022 127 citations Jonathan S. Nguyen‐Van‐Tam, Roman Fleischhackl et al. profile →

Peers

Countries citing papers authored by Jonathan S. Nguyen‐Van‐Tam

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Nguyen‐Van‐Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Nguyen‐Van‐Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Nguyen‐Van‐Tam more than expected).

Fields of papers citing papers by Jonathan S. Nguyen‐Van‐Tam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Nguyen‐Van‐Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Nguyen‐Van‐Tam. The network helps show where Jonathan S. Nguyen‐Van‐Tam may publish in the future.

Co-authorship network of co-authors of Jonathan S. Nguyen‐Van‐Tam

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Nguyen‐Van‐Tam. A scholar is included among the top collaborators of Jonathan S. Nguyen‐Van‐Tam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Nguyen‐Van‐Tam. Jonathan S. Nguyen‐Van‐Tam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study 2024 ·The Lancet Rheumatology ·Georgina Nakafero, Matthew J. Grainge, Tim Card, Christian Mallen, Jonathan S. Nguyen‐Van‐Tam, Abhishek Abhishek	2
2	Care Coordination Between Family Physicians and Palliative Care Physicians for Patients With Cancer: Results of a Quality Improvement Initiative 2024 ·JCO Oncology Practice ·(unknown), Jonathan S. Nguyen‐Van‐Tam, Leonie Herx, (unknown), (unknown), (unknown), (unknown), Aynharan Sinnarajah, Jean Mathews	2
3	Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study 2024 ·BMJ Open Gastroenterology ·Georgina Nakafero, Matthew J. Grainge, Tim Card, Christian Mallen, Jonathan S. Nguyen‐Van‐Tam, Abhishek Abhishek	0
4	Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable 2023 ·Expert Review of Vaccines ·Chiara de Waure, Barbara C. Gärtner, Pier Luigi Lopalco, Joan Puig‐Barberà, Jonathan S. Nguyen‐Van‐Tam	3
5	Is Vaccination Against COVID-19 Associated With Inflammatory Bowel Disease Flare? Self-Controlled Case Series Analysis Using the UK CPRD 2023 ·The American Journal of Gastroenterology ·Tim Card, Georgina Nakafero, Matthew J. Grainge, Christian Mallen, Jonathan S. Nguyen‐Van‐Tam, Hywel C Williams, Abhishek Abhishek	7
6	Cumulative incidence of post‐infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis 2020 ·Influenza and Other Respiratory Viruses ·Jonathan S. Nguyen‐Van‐Tam, Veronique Wyffels, Maartje Smulders, (unknown), (unknown), Nikhil Gupta, Sandra Gavart, Roman Fleischhackl	10
7	Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases 2020 ·Influenza and Other Respiratory Viruses ·P. Jacob Bueno de Mesquita, Jonathan S. Nguyen‐Van‐Tam, Ben Killingley, Joanne Enstone, Rob Lambkin‐Williams, Anthony Gilbert, Alex Mann, John Forni, Jing Yan, Jovan Pantelic, Michael L. Grantham, Donald K. Milton	5
8	Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza 2018 ·BMC Health Services Research ·Naomi Bradbury, Jonathan S. Nguyen‐Van‐Tam, Wei Shen Lim	3
9	Guidance on the use of respiratory and facial protection equipment 2013 ·Journal of Hospital Infection ·John Coia, (unknown), Anil Adisesh, Catherine Booth, C.W. Bradley, (unknown), Gail Carson, Carole Fry, Peter Hoffman, David R. Jenkins, Nick Phin, Bruce Taylor, Jonathan S. Nguyen‐Van‐Tam, Molly K. Zuckerman	104
10	Routes of influenza transmission 2013 ·Influenza and Other Respiratory Viruses ·Ben Killingley, Jonathan S. Nguyen‐Van‐Tam	166
11	Differences between asthmatics and nonasthmatics hospitalised with influenza A infection 2012 ·European Respiratory Journal ·Puja Myles, Jonathan S. Nguyen‐Van‐Tam, Malcolm G. Semple, Stephen J. Brett, Barbara Bannister, Robert C. Read, Bruce L. Taylor, Jim McMenamin, Joanne Enstone, Karl G. Nicholson, Peter Openshaw, Wei Shen Lim	35
12	Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic 2012 ·Influenza and Other Respiratory Viruses ·Charles Beck, Rachel Sokal, (unknown), Richard Puleston, (unknown), Anthony Kessel, Maria Zambon, Jonathan S. Nguyen‐Van‐Tam, (unknown)	9
13	Immunogenicity and safety of a two-dose schedule of whole-virion and AS03(A)-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial 2011 ·Leicester Research Archive (University of Leicester) ·(unknown), Keith R. Abrams, Sally Batham, (unknown), Katja Höschler, (unknown), (unknown), Jonathan S. Nguyen‐Van‐Tam, Robert C. Read, Fiona C Warren, Maria Zambon	5
14	Late-breaking abstract: Relationship of asthma to outcome in influenza A/H1N1 2009 infection: FLU-CIN cohort study 2011 ·European Respiratory Journal ·Malcolm G. Semple, Wei Shen Lim, Puja Myles, Joanne Enstone, Peter Openshaw, Robert C. Read, Bruce Taylor, James McMenamin, Barbara Bannister, Stephen J. Brett, Karl G. Nicholson, Jonathan S. Nguyen‐Van‐Tam	1
15	Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings 2010 ·Health Technology Assessment ·Ben Killingley, Jane Greatorex, Simon Cauchemez, J.E. Enstone, Martin D. Curran, Robert C. Read, Wee Shiong Lim, Andrew Hayward, (unknown), Jonathan S. Nguyen‐Van‐Tam	33
16	Uptake and acceptability of influenza vaccination in day nursery children. 2007 ·PubMed ·Tracey Chantler, David Pace, (unknown), (unknown), Ly‐Mee Yu, Jonathan S. Nguyen‐Van‐Tam, Noni MacDonald	11
17	Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care 2003 ·Journal of the Royal Society of Medicine ·(unknown), Jonathan S. Nguyen‐Van‐Tam, Andrew Hayward	6
18	Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. 1999 ·PubMed ·Jonathan S. Nguyen‐Van‐Tam, Keith Neal	24
19	Health care experiences of Vietnamese families in Nottingham. 1996 ·PubMed ·Jonathan S. Nguyen‐Van‐Tam, John B. Simpson, (unknown), Louise Davies	5
20	Influenza immunisation: policies and practices of general practitioners in England, 1991/92. 1993 ·PubMed ·Jonathan S. Nguyen‐Van‐Tam, K. G. Nicholson	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact